PALO ALTO, Calif., Nov. 22, 2024 (GLOBE NEWSWIRE) -- Orbus Therapeutics, Inc., a private pharmaceutical company, today announced that the combination of eflornithine and lomustine achieved a ...

Newly formed executive team initiates global search for differentiated therapeutic assets for neurology and oncology indications, ... · ACCESS Newswire · CNS Pharmaceuticals, Inc. "Berubicin is being ...

Review the side-effects of Lomustine as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

When the sole manufacturer withdrew a critical cancer drug from Medicare and Medicaid, patients were left without options. Policy makers must act to ensure that essential drugs remain affordable and ...

HealthDay News — In patients with progressive glioblastoma, treatment with lomustine plus bevacizumab does not confer a survival advantage over treatment with lomustine alone, according to a study ...

Lomustine (Lomustine ) is an alkylating agent, prescribed for certain types of cancer. It stops or slows the growth of cancer cells. The information provided on this page is intended to serve as a ...

Reiterative Survival Analyses of Total Therapy 2 for Multiple Myeloma Elucidate Follow-Up Time Dependency of Prognostic Variables and Treatment Arms In order to evaluate the impact of lomustine in a ...

Relationship Between Plasma Estradiol Levels and Estrogen-Responsive Gene Expression in Estrogen Receptor–Positive Breast Cancer in Postmenopausal Women Patients were randomly assigned 2:1 to receive ...

Although the success of auto-HSCT depends on several variables, the lower the toxicity and the duration of neutropenia the smaller the treatment-related mortality. Given that lomustine has low ...

Please provide your email address to receive an email when new articles are posted on . Lomustine added to standard induction therapy improved complete remission and survival in patients aged older ...